AXIM Biotechnologies, Inc. Company Review & Valuation

AXIM
OTC Markets
Latest Price
0.42USD
Market Capitalization
56.64mUSD

About AXIM Biotechnologies, Inc.

Axim Biotechnologies, Inc., a biotechnology company, researches, develops, produces, and sells pharmaceutical, nutraceutical and cosmetic, and genetically controlled botanical products.

It also engages in the extraction and purification of cannabinoids technologies based on its proprietary technologies.

The company sells its products through Internet, direct-to-consumer health and wellness stores, collectives, cooperatives, and affiliate sales and master distributors.

Axim Biotechnologies, Inc.

was formerly known as Axim International Inc.

and changed its name to Axim Biotechnologies, Inc.

in July 2014.

The company was founded in 2010 and is based in New York, New York.

Industry
Biotechnology
HQ Location
New York, New York

Stock Price

Price data not available for AXIM Biotechnologies, Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl